Drug therapy in the hepatic patient

J. R. Laporte

Drug therapy in the hepatic patient

Research output: Contribution to journal › Article › Research › peer-review

Abstract

It is confirmed that the effect of drugs in the body does not vary with the same intensity in hepatopathies as it does in nephropathies; this is attributed to the genetic constitution of each individual and the induction of the microsomal enzymatic systems. It has been observed both in hepatopathies with a deficient conjugation of bilirubin as well as in acquired hepatopathies that there are significant differences for certain drugs. As regards acquired hepatopathies, the data available indicate that the pathway most profoundly affected is acetylation, thereby affecting drugs, which are actylated in the liver; other pathways and conjugations will be less severely affected.

Original language	English
Pages (from-to)	165-172
Journal	Progres Medical
Volume	102
Issue number	5
Publication status	Published - 1 Jan 1974

Fingerprint Dive into the research topics of 'Drug therapy in the hepatic patient'. Together they form a unique fingerprint.

Cite this

@article{b05673258d504c13bd3b631de6e8e189,

title = "Drug therapy in the hepatic patient",

abstract = "It is confirmed that the effect of drugs in the body does not vary with the same intensity in hepatopathies as it does in nephropathies; this is attributed to the genetic constitution of each individual and the induction of the microsomal enzymatic systems. It has been observed both in hepatopathies with a deficient conjugation of bilirubin as well as in acquired hepatopathies that there are significant differences for certain drugs. As regards acquired hepatopathies, the data available indicate that the pathway most profoundly affected is acetylation, thereby affecting drugs, which are actylated in the liver; other pathways and conjugations will be less severely affected.",

author = "Laporte, {J. R.}",

year = "1974",

month = jan,

day = "1",

language = "English",

volume = "102",

pages = "165--172",

number = "5",

}

TY - JOUR

T1 - Drug therapy in the hepatic patient

AU - Laporte, J. R.

PY - 1974/1/1

Y1 - 1974/1/1

N2 - It is confirmed that the effect of drugs in the body does not vary with the same intensity in hepatopathies as it does in nephropathies; this is attributed to the genetic constitution of each individual and the induction of the microsomal enzymatic systems. It has been observed both in hepatopathies with a deficient conjugation of bilirubin as well as in acquired hepatopathies that there are significant differences for certain drugs. As regards acquired hepatopathies, the data available indicate that the pathway most profoundly affected is acetylation, thereby affecting drugs, which are actylated in the liver; other pathways and conjugations will be less severely affected.

AB - It is confirmed that the effect of drugs in the body does not vary with the same intensity in hepatopathies as it does in nephropathies; this is attributed to the genetic constitution of each individual and the induction of the microsomal enzymatic systems. It has been observed both in hepatopathies with a deficient conjugation of bilirubin as well as in acquired hepatopathies that there are significant differences for certain drugs. As regards acquired hepatopathies, the data available indicate that the pathway most profoundly affected is acetylation, thereby affecting drugs, which are actylated in the liver; other pathways and conjugations will be less severely affected.

M3 - Article

VL - 102

SP - 165

EP - 172

IS - 5

ER -